Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)

Laurent Peyrin-Biroulet, Edward V. Loftus, Jean Frédéric Colombel, Silvio Danese, Raquel Rogers, Jeffrey D. Bornstein, Jingjing Chen, Stefan Schreiber, Bruce E. Sands, Richard A. Lirio

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)'. Together they form a unique fingerprint.

Medicine & Life Sciences